Micro Systems Engineering Competitors and Similar CompaniesClear all

Cardiovascular Systems's competitors and similar companies include AtriCure, Cynosure and Accuray.

	Cardiovascular Systems Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD).	AtriCure AtriCure is a medical device company providing atrial fibrillation solutions.	Cynosure Cynosure is a company that develops and manufactures aesthetic and medical treatment systems.	Accuray Accuray is a radiation therapy company that develops, manufactures, sells, and supports radiation treatment solutions.
Founding Date	Founding Date 1989	Founding Date 2000	Founding Date 1991	Founding Date 1990
Type	Type Public	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare distribution medical devices medtech professional education	Tags Healthcare clinics healthtech medical devices medtech surgical solutions	Tags Manufacturing & Industrial health & beauty lasers medical devices	Tags Manufacturing & Industrial medical devices medtech oncology therapy
Locations	Locations Saint Paul, US HQ	Locations Mason, US HQ Amsterdam, NL Minnetonka, US Pleasanton, US	Locations Westford, US HQ Pymble, AU Hangzhou, CN Suzhou, CN Courbevoie, FR Langen (Hessen), DE Tokyo, JP see more	Locations Madison, US HQ Chengdu, CN Kowloon, HK Tokyo, JP Morges, CH Santa Clara, US Sunnyvale, US
Employees	Employees 7257% decrease	Employees 1,05020% increase	Employees 8141% decrease	Employees 9874% decrease
Valuation ($)	Valuation ($) 844 m	Valuation ($) 1.4 b	Valuation ($) N/A	Valuation ($) 186.5 m
Financial
Revenue (est.)	Revenue (est.) $236.2m (FY, 2022)	Revenue (est.) $399.2m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $446.6m (FY, 2024)
Cost of goods	Cost of goods $63.4m (FY, 2022)	Cost of goods $98.9m (FY, 2023)	Cost of goods N/A	Cost of goods $303.6m (FY, 2024)
Gross profit	Gross profit $172.8m (FY, 2022)	Gross profit $300.4m (FY, 2023)	Gross profit N/A	Gross profit $142.9m (FY, 2024)
Net income	Net income ($36.9m) (FY, 2022)	Net income ($30.4m) (FY, 2023)	Net income N/A	Net income ($15.5m) (FY, 2024)
Operating ⚠
Facility Space Leased, sq. ft.	Facility Space Leased, sq. ft. N/A	Facility Space Leased, sq. ft. 178.5 k (FY, 2022)	Facility Space Leased, sq. ft. N/A	Facility Space Leased, sq. ft. 384 k (FY, 2019)
Products	Products N/A	Products 6 (FY, 2022)	Products 20 (FY, 2016)	Products N/A
Funding
Total funding raised	Total funding raised $ 69m	Total funding raised $ 8.5m	Total funding raised N/A	Total funding raised N/A